drugset / Trial / NCT03748147
Cervical Ripening in Obese Women: Efficacy of 25 mcg Versus 50 mcg of Misoprostol
RandomizedSingle-groupTriple-blindTreatment
Summary
This is a prospective clinical trial to determine if 50 mcg versus 25 mcg po every four hours of misoprostol has improved efficacy and similar safety in obese women undergoing cesarean section.
Timeline
- Start
- 2018-12-10
- Primary completion
- 2020-06-01
- Completion
- 2021-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Misoprostol | Other / unclassified | 25 ug | Oral |
| Subject | Misoprostol | Other / unclassified | 50 ug | Oral |